Technology
Health
Pharmaceutical

Tetraphase Pharmaceuticals

$0.395
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0054 (-1.35%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TTPH and other stocks, options, ETFs, and crypto commission-free!

About TTPH

Tetraphase Pharmaceuticals, Inc. Common Stock, also called Tetraphase Pharmaceuticals, is engaged in the development and production of novel antibiotics for serious and life-threatening bacterial infections. Read More It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Employees
119
Headquarters
Watertown, Massachusetts
Founded
2006
Market Cap
21.52M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
400.78K
High Today
$0.44
Low Today
$0.3918
Open Price
$0.44
Volume
374.81K
52 Week High
$3.66
52 Week Low
$0.3918

Collections

Technology
Health
Pharmaceutical
2013 IPO
US
North America

TTPH Earnings

-$0.64
-$0.49
-$0.33
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.